Paragon Therapeutics, Inc. SEC EDGAR Filings (CIK 0001861055)

SEC EDGAR filings, ownership reports, and insider transactions for Paragon Therapeutics, Inc..

Business address
C/O Fairmount Funds Management, Llc, 2001 Market Street, Suite 2500, Philadelphia, PA, 19103
Top holdings (Schedule 13G)
GLTO
State of incorporation
DE
Fiscal year end
31 December
Paragon Therapeutics, Inc. has filed 2 SEC EDGAR filings since 10 May 2021

Latest Filings

Recent SEC filings for Paragon Therapeutics, Inc. including SCHEDULE 13G, D.

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 12 Jan 2026
D Open D document View SEC filing for D 10 May 2021 021-398700

About this filer

Paragon Therapeutics, Inc. files with the SEC under CIK 0001861055. This page aggregates EDGAR filings and related ownership activity.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages